The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future

JM Foster, C Zhang, S Rehman… - CA: A Cancer …, 2023 - Wiley Online Library
Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions

JB Karpes, R Shamavonian, S Dewhurst, E Cheng… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a malignancy of mesothelial tissues. The majority arise
from the pleura, but approximately thirty percent of cases arise from the peritoneum …

Silver nanoparticles: An instantaneous solution for anticancer activity against human liver (HepG2) and breast (MCF-7) cancer cells

AA Al-Khedhairy, R Wahab - Metals, 2022 - mdpi.com
Cancer is a cataclysmic disease that affects not only the target organ, but also the whole
body. Metal-based nanoparticles (NPs) have recently emerged as a better option for the …

[HTML][HTML] Molecular characterization of peritoneal mesotheliomas

M Offin, SR Yang, J Egger, G Jayakumaran… - Journal of Thoracic …, 2022 - Elsevier
Abstract Introduction Malignant peritoneal mesothelioma (MPeM) is clinically distinct and
less studied than malignant pleural mesothelioma. We report the genomic and …

Clinacanthus nutans crude polysaccharide extract as a green platform for microwave-assisted synthesis of silver nanoparticles: optimization, characterization, and …

K Devasvaran, B Alallam, C Lee, YK Yong… - International Journal of …, 2024 - Elsevier
Clinacanthus nutans (C. nutans) is a plant in tropical Asia with proven biological activities.
The optimized extraction method of C. nutans crude polysaccharide (CNP) uses water in the …

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: work still in progress

M Perrino, F De Vincenzo, N Cordua, F Borea… - Frontiers in …, 2023 - frontiersin.org
Malignant mesothelioma (MM) is a rare and aggressive neoplasm, usually associated with a
poor prognosis (5 years survival rate< 10%). For unresectable disease, platinum and …

Biomarkers for malignant pleural mesothelioma—A novel view on inflammation

M Vogl, A Rosenmayr, T Bohanes, A Scheed… - Cancers, 2021 - mdpi.com
Simple Summary In view of the recent advances in immunoncology, we want to reevaluate
and summarize the role of the immune system in malignant pleural mesothelioma (MPM) …

Peritoneal mesothelioma—an update

A Malpica - Advances in anatomic pathology, 2023 - journals.lww.com
A remarkable amount of new information has been generated on peritoneal mesothelioma
(PeM), ranging from nomenclature changes, including the removal of “malignant” when …

Mechanisms of PD-L1 regulation in malignant and virus-infected cells

H Farrukh, N El-Sayes, K Mossman - International Journal of Molecular …, 2021 - mdpi.com
Programmed cell death protein 1 (PD-1), a receptor on T cells, and its ligand, PD-L1, have
been a topic of much interest in cancer research. Both tumour and virus-infected cells can …

Treatment of patients with malignant peritoneal mesothelioma

CY Li, T Kennedy, HR Alexander - Journal of Clinical Medicine, 2022 - mdpi.com
Malignant peritoneal mesothelioma is a rare malignancy arising from the serosa of the
peritoneal cavity. It is diagnosed based on suspicious findings on cross sectional imaging …